Zusammenfassung
5-Methyl-3-(2-methylallyl)-2-[(3-methyl-4-oxo-2-thiazolidinyliden)-hydrazono]-4-thiazolidinon erwies sich bei guter therapeutischer Breite als stark karzinostatisch wirksam bei DMBA-induzierten Mamma-Karzinomen weiblicher Sprague-Dawley Ratten. Eine geringere chemotherapeutische Wirkung fand sich auch bei Walker CaSa 256, DMBA-induzierten Hautkarzinomen und Ehrlich Ascites Karzinom.
References
Ch. Huggins, L. C. Grand andF. P. Brillantes, Nature, Lond.189, 204 (1961).
No placebo-treated control group was included in these experiments, since the vehicle used for the suspension of GP 48 989 had previously been shown to be indifferent.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt-Ruppin, K.H., Meisels, A., Schott, E. et al. Carcinostatic activity of a thiazolidinonylidene-hydrazonothiazolidinone derivative against DMBA-induced mammary carcinomata in female Sprague-Dawley rats. Experientia 29, 823–825 (1973). https://doi.org/10.1007/BF01946310
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01946310